Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22166323 | 0.92 | KMT2A (0.54) | KMT2AMEN1TSHRMAPK1ALDH1A1 | |
| SCHEMBL8329121 | 0.87 | KMT2A (0.61) | KMT2AMEN1TSHRMAPK1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL5630497 | 0.86 | KMT2A (0.52) | KMT2AMEN1TSHRMAPK1ALDH1A1 | |
| SCHEMBL18542336 | 0.85 | KMT2A (0.54) | KMT2AMEN1TSHRMAPK1ALDH1A1 | |
| SCHEMBL9227908 | 0.85 | KMT2A (0.59) | KMT2AMEN1TSHRMAPK1ALDH1A1 | |
| SCHEMBL18542334 | 0.85 | KMT2A (0.49) | KMT2AMEN1TSHRMAPK1ALDH1A1 | |
| SCHEMBL9119816 | 0.85 | KMT2A (0.54) | KMT2AMEN1TSHRMAPK1ALDH1A1 | |
| SCHEMBL5756345 | 0.83 | KMT2A (0.57) | KMT2AMEN1TSHRMAPK1ALDH1A1 | |
| SCHEMBL20083930 | 0.83 | KMT2A (0.57) | KMT2AMEN1TSHRMAPK1ALDH1A1 | |
| SCHEMBL18542335 | 0.82 | ALDH1A1 (0.60) | KMT2AMEN1TSHRALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230010535-A1 | ELECTROACTIVE COMPOUNDS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2023-01-12 | — | — | US | disclosed |
| WO-2021126593-A1 | ELECTROACTIVE COMPOUNDS | DUPONT ELECTRONICS, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230010535-A1 | ELECTROACTIVE COMPOUNDS | NR4A2, NR2C2, ESR2 | KMT2A 928/4885MEN1 1209/4885TSHR 1089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.